The TARGET-NASH Study Finds Prior Opioid Use Prevalent in NAFLD Patients
Target RWE, an innovative health evidence solutions company based in Durham, North Carolina recently announced its current data from the study of nonalcoholic steatohepatitis (NASH) via PRNewswire. The study, entitled…